Radnor Capital Management LLC Has $777,000 Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Radnor Capital Management LLC trimmed its position in Henry Schein, Inc. (NASDAQ:HSIC) by 25.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,235 shares of the company’s stock after selling 3,855 shares during the quarter. Radnor Capital Management LLC’s holdings in Henry Schein were worth $777,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Cromwell Holdings LLC boosted its holdings in Henry Schein by 93.4% during the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after purchasing an additional 170 shares in the last quarter. Versant Capital Management Inc lifted its position in shares of Henry Schein by 274.6% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $32,000 after buying an additional 335 shares during the period. City State Bank acquired a new stake in Henry Schein in the 4th quarter valued at $55,000. Farther Finance Advisors LLC boosted its stake in Henry Schein by 58.9% in the 3rd quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock valued at $68,000 after buying an additional 346 shares in the last quarter. Finally, Livforsakringsbolaget Skandia Omsesidigt grew its position in Henry Schein by 282.1% in the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company’s stock valued at $109,000 after acquiring an additional 1,100 shares during the period. 96.62% of the stock is owned by institutional investors.

Insider Buying and Selling

In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of the firm’s stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the transaction, the chief operating officer now directly owns 87,706 shares of the company’s stock, valued at approximately $6,577,950. This trade represents a 12.25 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.14% of the stock is currently owned by insiders.

Henry Schein Stock Down 0.2 %

NASDAQ HSIC opened at $71.15 on Thursday. The stock has a market capitalization of $8.87 billion, a P/E ratio of 29.28, a price-to-earnings-growth ratio of 2.30 and a beta of 0.89. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.63. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The stock has a fifty day moving average of $72.18 and a 200-day moving average of $70.57.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, topping analysts’ consensus estimates of $1.17 by $0.05. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. During the same period last year, the company earned $1.32 earnings per share. The company’s revenue was up .4% on a year-over-year basis. On average, equities research analysts forecast that Henry Schein, Inc. will post 4.78 EPS for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the stock. Mizuho started coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price on the stock. Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and boosted their price target for the company from $69.00 to $84.00 in a research report on Monday, January 6th. Evercore ISI raised their price objective on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. Barrington Research reissued an “outperform” rating and issued a $82.00 target price on shares of Henry Schein in a report on Wednesday, November 6th. Finally, StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Seven equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $79.40.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.